Inductos - supply shortage

Resolved

dibotermin alfa

Shortage information

The shortage affecting Inductos has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

• Medicines affected:
  Inductos
• Supply shortage status:
  Resolved
• International non-proprietary name (INN) or common name:
  dibotermin alfa
• Therapeutic area (MESH):
  • Tibial Fractures
  • Fracture Fixation, Internal
  • Spinal Fusion
• Pharmaceutical forms affected:
  Powder, solvent and matrix for implantation matrix
• Availability of alternatives:
  Yes

Key dates

• First published:
  16/09/2015
• Last updated:
  15/08/2017